Frontiers in Neurology | Multiple Sclerosis and Neuroimmunology

Original Research

Published on 04 Feb 2026

Serum neurofilament light chain and disease-modifying treatment as predictors of cognitive decline in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Vera Taluntiene
Natasa Giedraitiene
Rasa Kizlaitiene
Mantas Vaisvilas
Gintaras Kaubrys

Frontiers in Neurology

doi 10.3389/fneur.2026.1743472

265 views

Editorial

Accepted on 02 Feb 2026

Reviews in Neuroimmunology: An editorial

in Multiple Sclerosis and Neuroimmunology

Omid Mirmosayyeb

Frontiers in Neurology

200 views

Original Research

Accepted on 02 Feb 2026

The Lithuanian multiple sclerosis registry: current framework and quality challenges

in Multiple Sclerosis and Neuroimmunology

Julija Isačenko
Dalia Musneckienė
Rasa Kizliatienė
Nataša Giedraitienė
Romualdas Kizlaitis
Lina Malcienė
Dalius Jatuzis
Gintaras Kaubrys
Daiva Rastenyte

Frontiers in Neurology

Original Research

Published on 30 Jan 2026

Predictors of initiating high-efficacy vs. platform therapies as first-line disease-modifying treatment in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Khalid Bin Aziz
Thamer S. Alhowaish
Feras Alanazi
Mezyed Alghanim
Saleh Alkhreigi
Fahad Almubarak
Faisal Aleisa
Nouf AlTuwaijri
Raghad Alanazi
Yaser Al Malik

Frontiers in Neurology

doi 10.3389/fneur.2026.1738815

1,363 views

Original Research

Published on 28 Jan 2026

Neutrophil-to-apolipoprotein A1 ratio as a novel biomarker for prognosis in anti-NMDAR encephalitis: a retrospective cohort analysis

in Multiple Sclerosis and Neuroimmunology

Jinwei Zhang
Ling Ling
Lei Xiang
Zhiying Wang
Youming Li
Wei Yue

Frontiers in Neurology

doi 10.3389/fneur.2026.1725493

296 views

Review

Accepted on 27 Jan 2026

Enhancing the Endocannabinoid System to treat residual disease in Relapse-Free Multiple Sclerosis

in Multiple Sclerosis and Neuroimmunology

P Annovazzi
Marinella Clerico
Eleonora Cocco
Antonella Conte
GIROLAMA ALESSANDRA MARFIA
Marco Salvetti
Valentina Tomassini
R Totaro
Diego Centonze

Frontiers in Neurology

193 views

Original Research

Accepted on 27 Jan 2026

Machine Learning and Single-cell RNA Sequencing Analyses Identify MS-related Monocytes and a Five-Gene Candidate Biomarker Signature

in Multiple Sclerosis and Neuroimmunology

Di Pan
Xinyi Wei
Xiyan Kuang
Dan Yang

Frontiers in Neurology

143 views

Original Research

Published on 27 Jan 2026

Clinical characteristics of MOG antibody-positive anti-NMDAR encephalitis: a single-center retrospective study

in Multiple Sclerosis and Neuroimmunology

Xuan Zou
Guan-en Zhou

Frontiers in Neurology

doi 10.3389/fneur.2026.1742531

435 views

Original Research

Published on 26 Jan 2026

Experience of using anti-CD 20 therapies in multiple sclerosis patients in Kenya

in Multiple Sclerosis and Neuroimmunology

Nyambane Eunice
Tejal Patel
Jacqueline Mavuti
Juzar Hooker
Dilraj Sokhi

Frontiers in Neurology

doi 10.3389/fneur.2025.1681527

513 views

Original Research

Published on 20 Jan 2026

Differential diagnosis between NMOSD and MS: a retrospective study based on clinical and imaging features

in Multiple Sclerosis and Neuroimmunology

Ya-Nan Ma
Qian Wang
Si-Rong Ma
Li Yang
Yong Ding
Qing-Qiu Wu

Frontiers in Neurology

doi 10.3389/fneur.2026.1718736

776 views

Systematic Review

Published on 19 Jan 2026

The effects of fampridine on MS-related fatigue: a systematic review

in Multiple Sclerosis and Neuroimmunology

Mohsen Rastkar
Christian Cordano
Mahsa Ghajarzadeh
Bardia Nourbakhsh

Frontiers in Neurology

doi 10.3389/fneur.2025.1720316

571 views

Original Research

Accepted on 13 Jan 2026

Multimodal MRI Assessment of Neuroprotective Effects of Ofatumumab on Brain Structure, Function, and Clinical Correlates in Relapsing Multiple Sclerosis

in Multiple Sclerosis and Neuroimmunology

Xiaoshuang Wang
Jing An
Zhaoshi Zheng
Yingyu Zhang
Di Wang
Yaxin Qu
Qiurong Yang
Shuai Wang
Xuemei Han

Frontiers in Neurology

167 views

Original Research

Accepted on 13 Jan 2026

Analysis of the Incidence Status and Risk Factors for Immune-Mediated Neuropathies: A Single-Center Case-Control Study

in Multiple Sclerosis and Neuroimmunology

Yunlong Wang
Zhanchang Feng
Lingxiu Liu
Mengchao Wan

Frontiers in Neurology

Opinion

Published on 08 Jan 2026

Plasma exchange following immunoglobulins for Guillain-Barré-Syndrome: a persisting problematic practice?

in Multiple Sclerosis and Neuroimmunology

Guglielmo Lucchese

Frontiers in Neurology

doi 10.3389/fneur.2025.1712202

1,748 views

Original Research

Published on 08 Jan 2026

Add-on efgartigimod in myasthenic crisis: a promising treatment option

in Multiple Sclerosis and Neuroimmunology

Fangyi Shi
Jing Wang
Jiaxin Chen
Rong Lai
Li Feng
Hongyan Zhou
Xunsha Sun
Cunzhou Shen
Jiezhen Feng
Xin Huang

Frontiers in Neurology

doi 10.3389/fneur.2025.1696976

938 views

Original Research

Published on 05 Jan 2026

NEDA-3 using cladribine for multiple sclerosis: effectiveness data from a Norwegian hospital

in Multiple Sclerosis and Neuroimmunology

Nora Berg Bjørnevoll
Karl Bjørnar Alstadhaug

Frontiers in Neurology

doi 10.3389/fneur.2025.1698334

1,597 views

Systematic Review

Published on 02 Jan 2026

Vitamin D deficiency and multiple sclerosis relapse: a meta-analysis

in Multiple Sclerosis and Neuroimmunology

Yujing Zhang
Shasha Yu
Yu Zu
Jing Lv
Jianhua Chen
Xuedan Feng

Frontiers in Neurology

doi 10.3389/fneur.2025.1727615

1,400 views

Original Research

Accepted on 29 Dec 2025

B-cell Immune Repertoire analysis of autoimmune neurological syndrome with anti-GAD65 antibodies

in Multiple Sclerosis and Neuroimmunology

Tianya Dong
Siyuan Fan
Haitao Ren
Yinwei Sun
Hongzhi Guan
Jing Wang

Frontiers in Neurology

164 views

Original Research

Published on 15 Dec 2025

Anti-LGI1 encephalitis: clinical presentation, imaging features, and prognostic analysis

in Multiple Sclerosis and Neuroimmunology

Xin Chen
Qiuyan Liu
Xiaojuan Wang
Songke Lu
Shaomin Zuo
Han Zheng
Hongzhi Guan
Wei Li

Frontiers in Neurology

doi 10.3389/fneur.2025.1703647

1,547 views

Original Research

Published on 11 Dec 2025

Burden of comorbidities in people with multiple sclerosis: a population-based study in Catalonia

in Multiple Sclerosis and Neuroimmunology

Toni Mora

Frontiers in Neurology

doi 10.3389/fneur.2025.1699641

767 views

Original Research

Published on 05 Dec 2025

Alterations in plasma cytokine profiles in generalized myasthenia gravis following different immunotherapeutic regimens

in Multiple Sclerosis and Neuroimmunology

Zhuangzhuang Ren
Xihui Ma
Yudan Liu
Yufeng Zhang
Yuping Chen
Chenjing Sun
Feng Qiu

Frontiers in Neurology

doi 10.3389/fneur.2025.1728767

1,100 views

Original Research

Published on 04 Dec 2025

Differential diagnoses of MS in clinical practice: incidence and methods for differential diagnosis

in Multiple Sclerosis and Neuroimmunology

Tim Johannes Steinberg
Lucie Mayer
David Freudenstein
Karolina Müller
Klemens Angstwurm
Ralf A. Linker
De-Hyung Lee

Frontiers in Neurology

doi 10.3389/fneur.2025.1695071

1,004 views

Systematic Review

Published on 02 Dec 2025

Brain atrophy in NMOSD and MOGAD: a meta-analysis of volumetric and DTI biomarkers

in Multiple Sclerosis and Neuroimmunology

Ariel Rechtman
Omri Zveik
Adi Vaknin-Dembinsky

Frontiers in Neurology

doi 10.3389/fneur.2025.1703283

1,651 views

Review

Published on 02 Dec 2025

Complement activation in immunological neurological disorders: mechanisms and therapeutic strategies

in Multiple Sclerosis and Neuroimmunology

Jin Y. Chen
Nirav Sanghani
Kaitlyn Palmer
Yuebing Li
Feng Lin
Justin R. Abbatemarco

Frontiers in Neurology

doi 10.3389/fneur.2025.1695461

2,284 views

1,189 articles

articles

Serum neurofilament light chain and disease-modifying treatment as predictors of cognitive decline in multiple sclerosis

Reviews in Neuroimmunology: An editorial

The Lithuanian multiple sclerosis registry: current framework and quality challenges

Predictors of initiating high-efficacy vs. platform therapies as first-line disease-modifying treatment in multiple sclerosis

Neutrophil-to-apolipoprotein A1 ratio as a novel biomarker for prognosis in anti-NMDAR encephalitis: a retrospective cohort analysis

Enhancing the Endocannabinoid System to treat residual disease in Relapse-Free Multiple Sclerosis

Machine Learning and Single-cell RNA Sequencing Analyses Identify MS-related Monocytes and a Five-Gene Candidate Biomarker Signature

Clinical characteristics of MOG antibody-positive anti-NMDAR encephalitis: a single-center retrospective study

Experience of using anti-CD 20 therapies in multiple sclerosis patients in Kenya

Differential diagnosis between NMOSD and MS: a retrospective study based on clinical and imaging features

The effects of fampridine on MS-related fatigue: a systematic review

Multimodal MRI Assessment of Neuroprotective Effects of Ofatumumab on Brain Structure, Function, and Clinical Correlates in Relapsing Multiple Sclerosis

Analysis of the Incidence Status and Risk Factors for Immune-Mediated Neuropathies: A Single-Center Case-Control Study

Plasma exchange following immunoglobulins for Guillain-Barré-Syndrome: a persisting problematic practice?

Add-on efgartigimod in myasthenic crisis: a promising treatment option

NEDA-3 using cladribine for multiple sclerosis: effectiveness data from a Norwegian hospital

Vitamin D deficiency and multiple sclerosis relapse: a meta-analysis

B-cell Immune Repertoire analysis of autoimmune neurological syndrome with anti-GAD65 antibodies

Anti-LGI1 encephalitis: clinical presentation, imaging features, and prognostic analysis

Burden of comorbidities in people with multiple sclerosis: a population-based study in Catalonia

Alterations in plasma cytokine profiles in generalized myasthenia gravis following different immunotherapeutic regimens

Differential diagnoses of MS in clinical practice: incidence and methods for differential diagnosis

Brain atrophy in NMOSD and MOGAD: a meta-analysis of volumetric and DTI biomarkers

Complement activation in immunological neurological disorders: mechanisms and therapeutic strategies